Caisse nationale d'assurance maladie (Cnam)

The Caisse Nationale d'Assurance Maladie (CNAM) is France's national health insurance fund, responsible for managing social security reimbursements. Recent news highlights significant challenges and legislative shifts impacting its operations. The CNAM is currently involved in a major fraud investigation, with seven individuals indicted for defrauding the system of an estimated 58 million euros across 18 health centers. Concurrently, a new law aimed at combating social and fiscal fraud is progressing through the National Assembly, which could introduce measures like suspending unemployment benefits or restricting sick leave reimbursements for teleconsultations, sparking debate about its impact on vulnerable populations. Furthermore, a significant change is set to occur in March 2026, where prescriptions from non-contracted doctors (secteur 3) will no longer be reimbursed by the Assurance-maladie, affecting a small but notable portion of medical professionals. These developments underscore the CNAM's current relevance in addressing fraud, adapting to new legislation, and navigating changes in healthcare provider reimbursement policies.